ACHL
Achilles Therapeutics Plc - ADR

934
Loading...
Loading...
News
all
press releases
Contrasting Achilles Therapeutics (NASDAQ:ACHL) & DBV Technologies (NASDAQ:DBVT)
Achilles Therapeutics (NASDAQ:ACHL - Get Free Report) and DBV Technologies (NASDAQ:DBVT - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast...
Zolmax·1y ago
News Placeholder
More News
News Placeholder
Achilles Therapeutics price target lowered by $5 at Chardan, here's why
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Piper Sandler gets more bearish on Achilles Therapeutics, downgrades shares
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights
Provided interim Phase I/IIa update on clonal neoantigen reactive T cells in advanced NSCLC and melanoma Improved VELOS manufacturing process delivering higher cNeT doses Protocols updated...
Globe Newswire·1y ago
News Placeholder
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning
Improved VELOS manufacturing process delivering higher cNeT doses Protocols updated to evaluate the benefit of enhanced host conditioning, with further data expected in 2H 2024 First three...
Globe Newswire·1y ago
News Placeholder
Reviewing Achilles Therapeutics (NASDAQ:ACHL) & IN8bio (NASDAQ:INAB)
IN8bio (NASDAQ:INAB - Get Free Report) and Achilles Therapeutics (NASDAQ:ACHL - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...
Ticker Report·1y ago
News Placeholder
Achilles Therapeutics plc (NASDAQ:ACHL) Sees Large Decrease in Short Interest
Achilles Therapeutics plc (NASDAQ:ACHL Get Free Report) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling...
Zolmax·1y ago
News Placeholder
Short Interest in Achilles Therapeutics plc (NASDAQ:ACHL) Declines By 79.5%
Achilles Therapeutics plc (NASDAQ:ACHL Get Free Report) saw a significant decrease in short interest in January. As of January 31st, there was short interest totalling 10,100 shares, a...
Ticker Report·2y ago
News Placeholder
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference
LONDON, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal...
Globe Newswire·2y ago
News Placeholder
Achilles Therapeutics plc (NASDAQ:ACHL) Sees Significant Increase in Short Interest
Achilles Therapeutics plc (NASDAQ:ACHL Get Free Report) saw a large increase in short interest in January. As of January 15th, there was short interest totalling 49,200 shares, an increase of...
Zolmax·2y ago

Latest ACHL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.